Twist Bioscience stock holds above key $93.53 support as buyers assess next move

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience stock slides 1.6% today

Highlights

Twist Bioscience supported AI-based enzyme design research by providing DNA materials for a study led by the David Liu lab.
There is no change reported in Twist Bioscience's product lineup, adoption, or commercial outlook from this collaboration.
Twist Bioscience stock retains a bullish technical structure, with buyers monitoring the $93.53 support and $106.46 resistance within an expected $87.88 to $111.01 range.

Twist Bioscience, via its official account, highlighted its role providing DNA materials for AI-driven enzyme design research led by the David Liu lab. The post centers on scientific collaboration and recognition within the research community. No change in product line, adoption, or commercial outlook is stated.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish momentum holds as market ignores illustrative post

The post offered no new data for the market to interpret, so price action evolved independently. For now, the bullish structure in Twist Bioscience stock is underpinned by price holding steadily above its MA-20, MA-50, and MA-200. Support also sits at the Ichimoku Kijun at $93.53, while RSI at 60.2 signals the rally may be getting stretched as it nears overbought conditions. The daily move stands out for running counter to the broader pattern, showing restraint as buyers assess the next step.

Upside bias favored as traders watch key resistance and overbought signals

To determine whether any fresh narrative is impacting price, traders should monitor moves relative to $93.53 support and the $106.46 area overhead. The strongest chart alert comes from RSI at 60.2, which is approaching overbought territory and warns that the advance could be reaching its short-term limits. Even after a sustained move higher with a firm trend, the outlook for the coming trading week features a very high probability (more than 80%) of upside and a very low probability (less than 20%) of downside, within an expected range of $87.88 to $111.01. A close above $106.46 would indicate buyers are willing to commit further, while a drop below $93.53 would suggest supply is overwhelming demand at recent levels. On the weekly chart, the longer-term setup remains firmly constructive.

Earlier, analysts noted that Twist Bioscience maintained a constructive technical outlook, supported by bullish momentum and a strong trend structure. The current research collaboration highlights the company's ongoing role in the scientific community, while traders should monitor whether price can sustain action above $93.53 support as the next directional move takes shape.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.